Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group. - Wikidata - wikimedia - TriplyDB

Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.

Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q37234602

about

Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer Renal late adverse effects after potentially nephrotoxic treatment for childhood cancer Acute kidney injury in children and its potential consequences in adulthood Impact of late radiation effects on cancer survivor children: an integrative review Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.Drug-induced acute kidney injury in children Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study Impact of Tailored Education on Awareness of Personal Risk for Therapy-Related Complications Among Childhood Cancer Survivors Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia.Premature Atherosclerotic Cardiovascular Disease in Childhood Cancer Survivors.Yield of Urinalysis Screening in Pediatric Cancer Survivors.Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Long-term nephrotoxicity in adult survivors of childhood cancer.Acute kidney injury in childhood: should we be worried about progression to CKD?Diversity in renal function monitoring and dose modifications during treatment for childhood cancer: a call for standardization.The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature.Paediatric cancer survivors demonstrate a high rate of subclinical renal dysfunction.Karyomegalic interstitial nephropathy following ifosfamide therapy.Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.Platinum compounds and sodium metabolism in children with diencephalic glioma.Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.Screening of renal dysfunction among Burkitt lymphoma survivors by novel markers.Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors

P2860

Q24197545-D28C5207-8BF6-41CE-92C6-F5C2B45851A6 Q24235075-EBE16454-2E3C-4A85-9451-36105D7A0BB8 Q27024927-24C6199E-CBC4-4770-ABDB-F0B70767BBF2 Q28085523-A89E46D3-A799-444C-AF15-247811FC64EF Q33628180-804DDD34-6D7F-4CD3-805D-5FB56A08C963 Q33999779-9F0B9C79-0D80-4E1C-8348-9B2451DC57ED Q35679310-3D8E5F71-C068-4431-BD1E-907AF0FE24C5 Q36125552-A0B4F0D2-9005-43D0-93FC-CB5DA5C0E902 Q36153146-3B9736B6-270A-4B50-958F-5AADF53D10AA Q36297411-E3F515F0-2A0B-4FA0-B57E-46F39D19463D Q36486436-0FDEBCCC-B9E4-4A18-840D-B545CEEF7C8F Q36498620-E3D37CA1-29EE-446D-BEE9-B653A81A993A Q36711759-373590EF-1AD9-4A94-8142-404AF0B105F2 Q36783762-912C9D57-A1B5-40A4-BEF8-0234793E49F7 Q36910939-8D91ED4A-4146-46BC-8B58-983457CBBA33 Q37799323-2BF57539-EA86-440B-9254-CDCF7389B9EE Q38125949-6CFD0AE6-160C-4E9E-A5F1-01C6B4276813 Q38641130-3B7031D3-5E28-4A06-B2E2-9593CCD169F0 Q38875402-4459FF5B-BE94-4CDF-85C9-C3E11C027430 Q40660424-80BEED2E-3C3B-48BB-84D7-2E886043F71E Q41902339-E2531DBF-5BA7-46E6-AA3E-4413BC15FE5B Q42274969-DD7660AF-7AEA-4B5B-9BD3-4506E1DD0719 Q43443976-80083FE5-4F9B-40B1-A7FA-31640669EEF9 Q47110433-D483C57B-F67D-45F3-AA85-FBFEB9801DA2 Q49569330-67A84C76-901A-4D04-9553-B051ACE19AEA Q51052452-92632D82-42BD-4997-83AC-6BA48F089B0A Q51258001-3A5D3F9F-7D7E-4506-BCAC-DB441BE2C423 Q57134277-BD0D14BF-CBB6-43C8-8F00-0167A3BC59F3

P2860

Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q37234602

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Renal late effects in patients ...... the Children's Oncology Group.

@en

Renal late effects in patients ...... the Children's Oncology Group.

@nl

type

label

Renal late effects in patients ...... the Children's Oncology Group.

@en

Renal late effects in patients ...... the Children's Oncology Group.

@nl

prefLabel

Renal late effects in patients ...... the Children's Oncology Group.

@en

Renal late effects in patients ...... the Children's Oncology Group.

@nl

P1433

Q37234602-5F6B23E8-8BF7-4580-976E-2DE4087D19CA

P1476

Q37234602-5CD3A4A2-3B20-446A-9B4E-A2A0DD90E385

P2093

Q37234602-31979661-1FF5-4F45-B065-5D3BED166EEF

Q37234602-3BC9AA6F-1AF9-4640-A0F2-3D595CF0215E

Q37234602-68290F6B-9113-485C-89B0-A294C5929492

Q37234602-6BAB1670-8809-4477-8A52-D82CFEC8EBDF

Q37234602-C9B8E0F0-2598-44BC-9EA6-1169B4D00A10

P2860

Q37234602-026619B6-F798-4E8E-A7E6-DEE612E993EF

Q37234602-072A09B2-76E6-4B5B-B101-87038EE51886

Q37234602-09C1B59E-7C72-4438-A384-E6C7E28ED597

Q37234602-0BBAC9EB-A7E2-4F87-B7F1-B3658D3BF114

Q37234602-123C1D9C-31B9-45CA-A735-79C806F70DDB

Q37234602-287B5ECA-1766-4468-B3FC-23CDBBC6F080

Q37234602-3E739487-62E9-4E09-B6B1-F84C011294E9

Q37234602-47D44941-5CD2-4AA8-A663-AF30EC650AC9

Q37234602-4CAD7B76-4D5D-4AFA-B1BC-C3157B46D5E2

Q37234602-4E9DD0BF-A55F-493E-8560-A16CD4247D0B

P304

Q37234602-85D529CA-DDE6-4E17-A61C-FEED054AE666

P31

Q37234602-B4523993-91A7-4634-966C-603F6D604597

P356

Q37234602-4BB367EA-50BA-4F00-816F-12E2B40BCC30

P433

Q37234602-4E7A3E00-F257-4C7D-A258-E51A861B22D8

P478

Q37234602-A31DEEEC-FD2F-4B9B-B5BD-51589A853E0B

P577

Q37234602-B57B16FB-855E-4F6C-B53F-F3E5226C90F6

P5875

Q37234602-8B214AE1-437A-4DB4-962D-4DA6A894F7F8

P698

Q37234602-77C7A6E0-5D38-466C-81DA-D8CD04BA9D68

P921

Q37234602-B6431409-4DC7-46FE-8FF0-FCF3554FD0CE

P932

Q37234602-C9B227F4-7620-45FD-B713-94BB3E25F622

P356

P1433

Pediatric Blood & Cancer

P1476

Renal late effects in patients ...... the Children's Oncology Group.

@en

P2093

Children's Oncology Group

http://www.w3.org/2001/XMLSchema#string

Daniel Green

http://www.w3.org/2001/XMLSchema#string

Deborah P Jones

http://www.w3.org/2001/XMLSchema#string

James E Springate

http://www.w3.org/2001/XMLSchema#string

Sheri L Spunt

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor

Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients

Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children

Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

Kidney and testicle injuries in team and individual sports: data from the national pediatric trauma registry.

End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.

Long-term complications and post-treatment follow-up of patients with Wilms' tumor.

Renal involvement in children with malignancies.

Chronic ifosfamide nephrotoxicity in children.

P304

724-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.21695

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23147042

http://www.w3.org/2001/XMLSchema#string

P698

18677764

http://www.w3.org/2001/XMLSchema#string

P921

P932

2734519

http://www.w3.org/2001/XMLSchema#string